However, the results of our study confirmed Bokhman’s scheme, as they showed that DFF40 and BCL2 expression levels were decreased in non-endometrioid and high-grade endometrial tumors compared with grade 1 and 2 ECs. Here, DFFB is linked to endometrium neoplasm.